In a filing, Akero Therapeutics Inc revealed its Senior VP, Commercial Strategy Lamy Patrick unloaded Company’s shares for reported $29130.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Akero Therapeutics Inc’s recent filing unveils that its Officer PATRICK D LAMY acquired Company’s shares for reported $28890.0 on Dec
Akero Therapeutics Inc’s filing revealed that its President and CEO Cheng Andrew unloaded Company’s shares for reported $0.8 million on
In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.25 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Akero Therapeutics Inc’s filing revealed that its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.25 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.35 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
